Published in BMC Vet Res on October 31, 2005
Novel calicivirus identified in rabbits, Michigan, USA. Emerg Infect Dis (2009) 1.32
Cytotoxicity of ORF3 proteins from a nonpathogenic and a pathogenic porcine circovirus. J Virol (2010) 0.88
A mouse model to study infection against porcine circovirus type 2: viral distribution and lesions in mouse. Virol J (2010) 0.83
Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway during porcine circovirus type 2 infection facilitates cell survival and viral replication. J Virol (2012) 0.80
Limited susceptibility of three different mouse (Mus musculus) lines to Porcine circovirus-2 infection and associated lesions. Can J Vet Res (2009) 0.77
The Porcine Circovirus Type 2 Nonstructural Protein ORF3 Induces Apoptosis in Porcine Peripheral Blood Mononuclear Cells. Open Virol J (2011) 0.75
Nitric oxide-generating compound GSNO suppresses porcine circovirus type 2 infection in vitro and in vivo. BMC Vet Res (2017) 0.75
In vivo characterization of chimeric PCV DNA clones containing heterogeneous capsid protein nuclear localization signals (NLS). Virol J (2013) 0.75
Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotides. J Vet Sci (2014) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 24.57
Caspases: enemies within. Science (1998) 19.45
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (1998) 8.93
Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature (1997) 5.35
A very small porcine virus with circular single-stranded DNA. Nature (1982) 4.35
Studies on epidemiology and pathogenicity of porcine circovirus. Arch Virol (1986) 3.58
First report of post-weaning multisystemic wasting syndrome in pigs in Spain. Vet Rec (1997) 3.45
Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome. Can Vet J (1998) 3.19
Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe. J Vet Diagn Invest (1998) 3.18
Characterization of papovavirus-and picornavirus-like particles in permanent pig kidney cell lines. Zentralbl Bakteriol Orig A (1974) 3.12
Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. J Gen Virol (1998) 2.90
Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J Gen Virol (2000) 2.45
Pathogenesis of porcine circovirus; experimental infections of colostrum deprived piglets and examination of pig foetal material. Vet Microbiol (1995) 2.36
Sequence of porcine circovirus DNA: affinities with plant circoviruses. J Gen Virol (1997) 2.32
Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol (1991) 2.12
Reproduction of lesions of postweaning multisystemic wasting syndrome in gnotobiotic piglets. J Vet Diagn Invest (1999) 1.98
Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J Virol (2005) 1.92
Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. J Virol (1998) 1.92
A single chicken anemia virus protein induces apoptosis. J Virol (1994) 1.91
Pathological, immunohistochemical, and in-situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs. J Comp Pathol (1999) 1.91
Viral wasting syndrome of swine: experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by coinfection with porcine circovirus 2 and porcine parvovirus. Vet Pathol (2000) 1.82
Apoptosis as a proinflammatory event: what can we learn from bacteria-induced cell death? Trends Microbiol (1997) 1.81
Detection of a novel strain of porcine circovirus in pigs with postweaning multisystemic wasting syndrome. J Clin Microbiol (1998) 1.73
Mapping and characterization of the origin of DNA replication of porcine circovirus. J Virol (1997) 1.71
Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci U S A (1997) 1.63
Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2). Vet Pathol (2001) 1.62
Detection and characterization of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. Can Vet J (1997) 1.44
Replication of porcine circovirus type 1 requires two proteins encoded by the viral rep gene. Virology (2001) 1.37
Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res (1995) 1.36
Characterization of viral DNAs from cells infected with chicken anaemia agent: sequence analysis of the cloned replicative form and transfection capabilities of cloned genome fragments. Arch Virol (1992) 1.32
A processed pseudogene in an intron of the HLA-DP beta 1 chain gene is a member of the ribosomal protein L32 gene family. Nucleic Acids Res (1985) 1.30
The pathology of psittacine beak and feather disease. Aust Vet J (1984) 1.29
PCR detection and characterization of type-2 porcine circovirus. Can J Vet Res (2000) 1.26
Circovirus-like viral associated disease in weaned pigs in Indiana. Vet Pathol (1998) 1.14
Postweaning multisystemic wasting syndrome induced after experimental inoculation of cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus. J Vet Diagn Invest (2001) 1.11
The chicken anemia virus-derived protein apoptin requires activation of caspases for induction of apoptosis in human tumor cells. J Virol (2000) 1.10
Viral replication and lesions in BALB/c mice experimentally inoculated with porcine circovirus isolated from a pig with postweaning multisystemic wasting disease. Vet Pathol (2001) 1.03
Apoptin, a protein encoded by chicken anemia virus, induces cell death in various human hematologic malignant cells in vitro. Leukemia (1995) 1.00
Circovirus-like infection in a pigeon. J Vet Diagn Invest (1993) 0.95
Hepatitis and staging of hepatic damage in pigs naturally infected with porcine circovirus type 2. Vet Pathol (2000) 0.91
Apoptosis and proliferative activity in lymph node reaction in postweaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol (2004) 0.91
Apoptosis in lymphoid organs of pigs naturally infected by porcine circovirus type 2. J Gen Virol (2004) 0.90
Immunohistochemical characterisation of the lymph node reaction in pig post-weaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol (2001) 0.88
BCL-2 stimulates Apoptin-induced apoptosis. Adv Exp Med Biol (1999) 0.87
Apoptin. Adv Exp Med Biol (2000) 0.87
The viral protein Apoptin induces apoptosis in UV-C-irradiated cells from individuals with various hereditary cancer-prone syndromes. Cancer Res (1999) 0.85
FGF-21 as a novel metabolic regulator. J Clin Invest (2005) 10.69
Isolation and characterization of porcine epidemic diarrhea viruses associated with the 2013 disease outbreak among swine in the United States. J Clin Microbiol (2013) 4.05
Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor. J Biol Chem (2003) 2.22
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet (2006) 2.10
Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus. Mol Ther (2008) 1.84
Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants. Vaccine (2007) 1.76
Emerging strategies for EphA2 receptor targeting for cancer therapeutics. Expert Opin Ther Targets (2011) 1.65
Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2006) 1.56
Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis. Blood (2008) 1.52
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine (2005) 1.51
Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption. Clin Cancer Res (2003) 1.50
Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1. Cancer Gene Ther (2004) 1.49
Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood (2009) 1.48
Current strategies and future directions for eluding adenoviral vector immunity. Curr Gene Ther (2006) 1.42
Retinoic acid determines the precise tissue tropism of inflammatory Th17 cells in the intestine. J Immunol (2010) 1.39
The impact of the National Patient Safety Agency intravenous fluid alert on iatrogenic hyponatraemia in children. Eur J Pediatr (2009) 1.38
Development of nonhuman adenoviruses as vaccine vectors. Vaccine (2005) 1.25
Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Clin Cancer Res (2006) 1.24
Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. Vaccine (2007) 1.19
Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture. Biochem Biophys Res Commun (2005) 1.19
Role of protein C in renal dysfunction after polymicrobial sepsis. J Am Soc Nephrol (2007) 1.18
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. J Infect Dis (2008) 1.13
Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants. Vaccine (2006) 1.11
Adenoviral vector immunity: its implications and circumvention strategies. Curr Gene Ther (2011) 1.07
Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture. Virus Res (2004) 1.03
Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines. Virology (2002) 1.02
Adenoviral vector-based strategies for cancer therapy. Curr Drug ther (2009) 1.02
Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model. Virology (2009) 1.02
Production of adenovirus vectors and their use as a delivery system for influenza vaccines. Expert Opin Biol Ther (2010) 1.01
Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine. PLoS One (2012) 1.00
Imject Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant. Vaccine (2007) 1.00
Developing a comprehensive mouse pathology program. Comp Med (2004) 0.99
Distinct functions of activated protein C differentially attenuate acute kidney injury. J Am Soc Nephrol (2008) 0.99
Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response. Vaccine (2010) 0.98
Adenovirus receptors and their implications in gene delivery. Virus Res (2009) 0.98
Training mouse pathologists: five years of pathology of mouse models of human disease workshops. Toxicol Pathol (2007) 0.97
Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy. Cancer Gene Ther (2005) 0.95
Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production. Vaccine (2003) 0.94
Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target. Expert Rev Mol Med (2010) 0.93
Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness. PLoS One (2013) 0.93
Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model. Virus Res (2010) 0.93
Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins. Pharm Dev Technol (2003) 0.92
Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3. Biochem Biophys Res Commun (2005) 0.91
Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin. Virology (2005) 0.90
Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. Vaccine (2004) 0.89
Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry. Virology (2009) 0.88
Distribution of adsorbed antigen in mono-valent and combination vaccines. Vaccine (2004) 0.86
Modulation of PKR activity in cells infected by bovine viral diarrhea virus. Virus Res (2005) 0.86
Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses. Hum Vaccin (2010) 0.85
Adverse vaccinal events in dogs and cats. Vet Clin North Am Small Anim Pract (2010) 0.83
Sequence analysis of old and new strains of porcine circovirus associated with congenital tremors in pigs and their comparison with strains involved with postweaning multisystemic wasting syndrome. Can J Vet Res (2002) 0.83
Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid. Vaccine (2005) 0.83
Prevalence and characterization of bovine viral diarrhea virus in the white-tailed deer population in Indiana. J Vet Diagn Invest (2008) 0.83
Congenital lobar emphysema and tension pneumothorax in a dog. J Vet Diagn Invest (2007) 0.81
Preformulation studies--The next advance in aluminum adjuvant-containing vaccines. Vaccine (2010) 0.81
EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model. J Gene Med (2012) 0.80
Vascular-associated lymphoid tissue in swine (Sus scrofa). Comp Med (2008) 0.79
Adenoviral E2 IVa2 protein interacts with L4 33K protein and E2 DNA-binding protein. J Gen Virol (2013) 0.79
Treatment of sepsis-induced acquired protein C deficiency reverses Angiotensin-converting enzyme-2 inhibition and decreases pulmonary inflammatory response. J Pharmacol Exp Ther (2008) 0.79
Evaluation of antithyroglobulin antibodies after routine vaccination in pet and research dogs. J Am Vet Med Assoc (2002) 0.79
A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production. Exp Hematol (2012) 0.78
Lack of association between repeated vaccination and thyroiditis in laboratory Beagles. J Vet Intern Med (2006) 0.78
Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer. Virus Res (2011) 0.78
Genotyping of Porcine teschovirus from nervous tissue of pigs with and without polioencephalomyelitis in Indiana. J Vet Diagn Invest (2010) 0.78
Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: history, experience, methodology, and future directions. Toxicol Pathol (2010) 0.78
Infection of cesarean-derived colostrum-deprived pigs with porcine circovirus type 2 and Swine influenza virus. Comp Med (2010) 0.77
Effects of cellulose derivatives and poly(ethylene oxide)-poly(propylene oxide) tri-block copolymers (Pluronic)surfactants) on the properties of alginate based microspheres and their interactions with phagocytic cells. J Control Release (2002) 0.77
Immunization of rabbits against a bacterial pathogen with an alginate microparticle vaccine. J Control Release (2002) 0.77
A 72-bp internal deletion in the left inverted terminal repeat of the bovine adenovirus type 3 genome does not affect virus replication. Intervirology (2002) 0.77
Adenoviral vector expressing murine β-defensin 2 enhances immunogenicity of an adenoviral vector based H5N1 influenza vaccine in aged mice. Virus Res (2013) 0.77
Activated protein C modulates chemokine response and tissue injury in experimental sepsis. Adv Exp Med Biol (2008) 0.76
Increased expression of chemokines in the skin of chronic proliferative dermatitis mutant mice. Exp Dermatol (2005) 0.76
Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines. Virus Res (2011) 0.75
Genes upregulated in a metastasizing human colon carcinoma cell line. Int J Cancer (2005) 0.75
Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time. Virus Res (2013) 0.75
Corrigendum: KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors. Sci Rep (2017) 0.75
Muscular pseudohypertrophy (steatosis) in a bovine fetus. J Vet Diagn Invest (2007) 0.75
Toxoplasmosis in a woodchuck (Marmota monax) and two American red squirrels (Tamiasciurus hudsonicus). J Vet Diagn Invest (2007) 0.75
Clinical investigation into feed-related hypervitaminosis D in a captive flock of budgerigars (Melopsittacus undulatus): morbidity, mortalities, and pathologic lesions. J Zoo Wildl Med (2015) 0.75
Catheter related bacteremia in rats: A preliminary report on the effect of methylene blue coated catheter. Indian J Exp Biol (2006) 0.75
Experimental co-infection of pigs with Bovine viral diarrhea virus 1 and Porcine circovirus-2. J Vet Diagn Invest (2011) 0.75
Carcinoma in a mixed mammary tumor in a llama (Lama glama). J Vet Diagn Invest (2007) 0.75
Lack of sumatriptan-induced aortic contraction or relaxation: 5-HT1B receptor protein detected in endothelium and smooth muscle of vasa vasorum but not aorta. Receptors Channels (2002) 0.75